Page 3 - Beth Kirkpatrick News Today

Friday, Oct. 1, 2021 Booster shots now available for more Vermonters MONTPELIER —The Agency of Human Services and the Department of Health announced that Pfizer-BioNTech COVID-19 vaccine booster doses are now available to people in Vermont who are 65 and ...

Sorely Needed Dengue Vaccine Gets a Boost from Immune Profiling Source: Pixabay May 26, 2021 A new study in the journal Nature Communications compares changes in gene expression in immune cells in humans before, during, and after infection with a partially weakened Dengue virus (rDEN2Δ30, ClinicalTrials.gov NCT02021968). Live, weakened or “attenuated” viruses are the basis for the most effective and durable vaccines against many viral diseases. The study finds that while the expression o...

 E-Mail Despite a daunting more than 130 million cases of SARS-CoV-2 infections to date worldwide, another global pathogen - the Aedes mosquito-borne dengue virus - saw a record number of over 400 million cases in 2019. But vaccine development has been challenging due to the need to protect equally against all four dengue strains. The discovery of new possible biomarkers to predict clinical and immune responses to dengue virus infection, published today in Nature Communication, could be criti...

UVM Medical Center pushing forward with AstraZeneca COVID-19 vaccine trial Several countries suspend use of the AstraZeneca vaccine. Share Updated: 7:09 PM EDT Mar 15, 2021 Several countries suspend use of the AstraZeneca vaccine. Share Updated: 7:09 PM EDT Mar 15, 2021 Hide Transcript Show Transcript NBC5 NEWS AT 6 STARTS NOW FOUR OF THE SIX... MOST POPULATED EUROPEAN COUNTRIES. ááSUSPENDING USE OF THE ASTRA ZENCA VACCINE. THANKS FOR JOINING US AT 6. IM B...

Joshua Schupp-Star getting vaccinated Joshua Schupp-Star can give you many reasons why he volunteered to join the clinical trial of an experimental COVID-19 vaccine at the University of Vermonts Vaccine Testing Center. All can be summarized in one word: hope. "After receiving my first dose, I got a taste of the freedom that existed before the pandemic," said Schupp-Star, who is among the 284 volunteers in Vermont to receive an as-yet-unapproved vac...

Related Company:  More Than 3,100 People Volunteer For Vaccine Study Vermont Business Magazine The University of Vermont Medical Center and the Vaccine Testing Center at the University of Vermonts Larner College of Medicine have successfully reached and surpassed the targeted number of enrollees for an ongoing Phase 3 clinical trial of the AstraZeneca COVID-19 vaccine. The goal of 250 enrolled and dosed volunteers was met in just four weeks – with more than 3,100 people registering to take p...